Report cover image

Global and China Osteoporosis Drugs Market, Global and China Osteoporosis Drugs Market, By Drug Type (Bisphosphonates, Alderonate, Risedronate, Ibandronate, Zoledronic Acid, Others, Calcitonin, Hormone Therapy, Selective Estrogen Receptor Modulators (SERM

Publisher Coherent Market Insights
Published Mar 25, 2025
Length 180 Pages
SKU # CMI20007838

Description

Osteoporosis is characterized by reduction in the density and quality of bones that often result in broken bones in the wrist, hip, and spine. Various factors responsible for osteoporosis include, genetic factors, low intake of calcium, magnesium, and vitamin D, eating disorders such as anorexia, inactivity and immobility, and excessive alcohol intake. Increasing approvals and launches of novel osteoporosis drugs along with increasing prevalence of osteoporasis is expected to significantly drive the osteoporosis treatment market growth over forecast period.

Key features of the study:
  • This report provides in-depth analysis of the Global and China Osteoporosis Drugs Market and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global and China Osteoporosis Drugs Market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Merck & Co., Eli Lilly, Procter & Gamble, Enzo Biochem, Inc., Sanofi-Aventis, Novartis, Wyeth, Roche, GlaxoSmithKline, UCB, Amgen, BeiGene Co., Ltd., Bone Biologics, Teijin Pharma Limited, JHL Biotech Inc., Keros Therapeutics, and Taro Pharmaceuticals Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global and China Osteoporosis Drugs Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global and China Osteoporosis Drugs Market
Detailed Segmentation:
  • Global and China Osteoporosis Drugs Market, By Drug Type:
  • Bisphosphonates
  • Alendronate
  • Risedronate
  • Ibandronate
  • Zoledronic Acid
  • Others
  • Calcitonin
  • Hormone Therapy
  • Selective Estrogen Receptor Modulators (SERMs)
  • Parathyroid Hormone-Related Protein (PTHrP) Analog
  • Rank Ligand (RANKL) Inhibitor
  • Global and China Osteoporosis Drugs Market, By Route of Administration:
  • Oral
  • Injectable
  • Others
  • Global and China Osteoporosis Drugs Market, By Distribution Channel:
  • Hospitals Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Global and China Osteoporosis Drugs Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • Company Profiles
  • Merck & Co.
  • Eli Lilly
  • Procter & Gamble
  • Enzo Biochem, Inc.
  • Sanofi-Aventis
  • Novartis
  • Wyeth
  • Roche.
  • GlaxoSmithKline
  • UCB
  • Amgen
  • BeiGene Co., Ltd.
  • Bone Biologics
  • Teijin Pharma Limited
  • JHL Biotech Inc.
  • Keros Therapeutics
  • Taro Pharmaceuticals Inc.

Table of Contents

180 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Drug Type
Market Snapshot, By Route of Administration
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
4. Global and China Osteoporosis Drugs Market– COVID-19 Impact Analysis
Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand
5. Global and China Osteoporosis Drugs Market, By Drug Type, 2020–2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021–2032
Segment Trends
Bisphosphonates
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Bn)
Alendronate
Risedronate
Ibandronate
Zoledronic Acid
Others
Calcitonin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Bn)
Hormone Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Bn)
Selective Estrogen Receptor Modulators (SERMs)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Bn)
Parathyroid Hormone-Related Protein (PTHrP) Analog
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Bn)
Rank Ligand (RANKL) Inhibitor
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Bn)
6. Global and China Osteoporosis Drugs Market, By Route of Administration, 2020–2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021–2032
Segment Trends
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Bn)
Injectable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Bn)
7. Global and China Osteoporosis Drugs Market, By Distribution Channel, 2020–2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021–2032
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Bn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020–2032, (US$ Bn)
8. Global and China Osteoporosis Drugs Market, By Region, 2020–2032, (US$ Bn)
Introduction
Market Share Analysis, By Region, 2025 and 2032 (%)
Y-o-Y Growth Analysis, For Regions, 2021–2032
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2032, (US$ Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2032, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020– 2032, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020–2032, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
China
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2020- 2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020– 2032, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020– 2032, (US$ Bn)
North Africa
Central Africa
South Africa
9. Competitive Landscape
Merck KGaA
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Lilly
Procter & Gamble
Enzo Biochem Inc.
Sanofi
Novartis AG
Wyeth Nutrition (A subsidiary of Pfizer Inc.)
Hoffmann-La Roche Ltd
GSP plc
UCB S.A.
Amgen Inc.
BeiGene, Inc.
Bone Biologics Corp
TEIJIN LIMITED
Eden Biologics (Formerly known as JHL Biotech Inc.)
Keros Therapeutics
Taro Pharmaceutical Industries Ltd.
10. Section
Research Methodology
About Us
*Browse 34 market data tables and 33 figures on “Osteoporosis Drugs Market”- forecast to 2032

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us